About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Fitch Ratings: Rating SpaceX's (SPCX.O) proposed senior unsecured bonds at "BBB+".

2026-06-22

Fitch Ratings: Rating SpaceX's (SPCX.O) proposed senior unsecured bonds at "BBB+".

Other News
2026-06-22

European stocks opened mixed on Monday, June 22: Germany's DAX up 16.39 pts (+0.07%) at 25,042.00; FTSE 100 up 11.48 pts (+0.11%) at 10,374.75; CAC 40 up 11.66 pts (+0.14%) at 8,432.80; Euro STOXX 50 up 17.97 pts (+0.29%) at 6,311.10; Spain's IBEX 35

European stocks opened mixed on Monday, June 22: Germany's DAX up 16.39 pts (+0.07%) at 25,042.00; FTSE 100 up 11.48 pts (+0.11%) at 10,374.75; CAC 40 up 11.66 pts (+0.14%) at 8,432.80; Euro STOXX 50 up 17.97 pts (+0.29%) at 6,311.10; Spain's IBEX 35 up 15.59 pts (+0.08%) at 19,362.99; Italy's FTSE MIB down 44.43 pts (-0.08%) at 52,804.50.
2026-06-22

June 22 — At a routine press briefing, Foreign Ministry spokesman Guo Jiakun said Beijing has noted media reports that Japanese forces invading China carried out human medical experiments in 1938. He called those live experiments and biological warfa

June 22 — At a routine press briefing, Foreign Ministry spokesman Guo Jiakun said Beijing has noted media reports that Japanese forces invading China carried out human medical experiments in 1938. He called those live experiments and biological warfare a lasting stain on history, warned Japan's "remilitarization" would be a backward step and a path of no return, and urged Tokyo to sincerely reflect on wartime crimes, fully severe ties with militarism, and take concrete steps to regain the trust of Asian neighbors and the international community.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.